Skip to content

Clinical study on the treatment of permanent pulp necrosis by allograft stem cells or apical papilla stem cells

Clinical study on the treatment of permanent pulp necrosis by allograft stem cells or apical papilla stem cells

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081768
Enrollment
Unknown
Registered
2024-03-11
Start date
2022-12-17
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Permanent pulp necrosis

Interventions

Experiment group 1:Allogeneic SCAP implantation therapy
Experiment group 2:Allogeneic SHED implantation therapy
Control group:Conventional root canal treatment

Sponsors

The Third Affiliated Hospital of PLA Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. Signing an informed consent form; 2. Age between 18 and 30 years old; 3. Anterior teeth or premolars with pulp necrosis due to caries, malformed central cusps, and wedge-shaped defects 4. (apical foramen diameter >=0.6mm), at least 1 tooth position (maximum 2 teeth position); 5. The researcher determines that the case is suitable for root canal treatment; 6. The researcher determines that the treated tooth can be preserved for at least 5 years; 7. The researcher determines that the affected tooth is eligible for stem cell implantation.

Exclusion criteria

Exclusion criteria: 1. The researcher determines that the study subject is unlikely to comply with the research procedures. 2. Uncontrollable pathological processes in the oral cavity. 3. Tooth occlusal trauma, bruxism, malocclusion. 4. The affected tooth accompanied by periapical cyst. 5. History of hereditary dental developmental disorders. 6. Cardiac diseases (Class II and above heart functional disorders). 7. Abnormal liver or kidney function (abnormal ALT, AST values; or creatinine, blood urea nitrogen values more than double the normal range). 8. Blood or immune system disorders. 9. Various infectious diseases. 10. Mental abnormalities or lack of behavioral autonomy. 11. Severe dental phobia. 12. Patients with hypersensitivity. 13. Women of childbearing age. 14. The researcher determines that systemic or local diseases may affect postoperative healing. 15. Planners and executors involved in the study.

Design outcomes

Primary

MeasureTime frame
Safety evaluation of allogeneic stem cell transplantation;

Secondary

MeasureTime frame
Recurrent-caries;

Countries

China

Contacts

Public ContactWei Wang

The Third Affiliated Hospital of PLA Air Force Medical University

weiwang_0510@163.com+86 137 5990 4768

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026